Jeffrey M. Dayno, M.D., is Chief Medical Officer for Harmony Biosciences. A nationally recognized expert in neuroscience, Dr. Dayno is currently responsible for managing research, development and medical and regulatory affairs for Harmony Biosciences.
He is a neurologist with 10 years experience in clinical/academic medicine followed by over 20 years experience in leadership roles at Merck & Co., Cephalon, and ViroPharma, building and leading clinical, regulatory and medical affairs teams toward multiple NDA approvals and medical support of successful product launches.
Dr. Dayno has served as Principal Investigator on numerous clinical trials and published and lectured extensively on various topics in the field of Neurology, with a focus on stroke, sleep disorders, pain and migraine. He has also served as a peer reviewer for several scientific neurology journals.
Dr. Dayno earned his medical degree from Temple University School of Medicine, did his residency training in Neurology at Temple University Hospital, and completed a fellowship in Stroke and Cerebrovascular Disorders in the Department of Neurology at Henry Ford Hospital.
What is Jeffrey M. Dayno's net worth?
The estimated net worth of Jeffrey M. Dayno is at least $597,171.48 as of March 31st, 2017. Dr. Dayno owns 18,212 shares of Harmony Biosciences stock worth more than $597,171 as of November 20th. This net worth approximation does not reflect any other investments that Dr. Dayno may own. Additionally, Dr. Dayno receives an annual salary of $1,260,000.00 as Insider at Harmony Biosciences. Learn More about Jeffrey M. Dayno's net worth.
How old is Jeffrey M. Dayno?
What is Jeffrey M. Dayno's salary?
How do I contact Jeffrey M. Dayno?
Has Jeffrey M. Dayno been buying or selling shares of Harmony Biosciences?
Who are Harmony Biosciences' active insiders?
Are insiders buying or selling shares of Harmony Biosciences?
In the last year, insiders at the sold shares 4 times. They sold a total of 33,869 shares worth more than $1,267,489.12. The most recent insider tranaction occured on October, 29th when insider Jeffrey Dierks sold 21,496 shares worth more than $869,943.12. Insiders at Harmony Biosciences own 30.8% of the company.
Learn More about insider trades at Harmony Biosciences. Information on this page was last updated on 10/29/2024.
